Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV
about
Influence of serum concentration on opsonization by the classical and alternative complement pathways.Alterations in serum opsonic activity and complement levels in pneumococcal disease.Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease.The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response.Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.A Three-Tiered Study of Differences in Murine Intrahost Immune Response to Multiple Pneumococcal Strains.Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls.Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assayImpaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathwayPneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complexSerum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigensCorrelation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniaeRelationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection.Measurement of immunoglobulin G and M antibodies to type 3 pneumococcal capsular polysaccharide by enzyme-linked immunosorbent assay.Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.Early clearance of pneumococci from the lungs of decomplemented rats.Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilliEffect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: comparison of sulphonamide sensitive and resistant strains
P2860
Q33899988-FA656C8A-D29F-4766-995C-C3681C8AA72CQ33907928-118B3ED8-6FA6-412B-96C3-8DF961EBDDE8Q33997459-890E2DB0-15A4-4468-A99E-3FFB734E9DB3Q34099154-44752B9E-7A1B-4A17-BCDF-C7B2B19137FEQ35191928-055EDBD8-B4BC-4A3C-AEB0-ACC43D40B9F4Q35317446-71CAAC5B-65D1-4A36-A33E-75707BBF5606Q35779863-A0B3A234-0ABA-4187-A83E-E69FE64F49DFQ35921138-D57D1045-6638-4FDB-98F4-55A486CDF268Q36428163-196990C6-FF39-47C7-8F14-50DD875DC4FDQ36437177-881FCDDB-A441-4EC9-A209-153D98C880BEQ36454624-8E595280-85D5-4C4A-ADBE-074C3514DB10Q36804267-3E85A988-E32C-4EFF-A16A-D697CC39DC70Q36963833-C6AAEB74-2D8D-40F8-9822-8882EB925AF8Q36972189-8B5BAE20-6663-4888-89EA-35C9E1459F05Q36998931-17D1089C-2026-4CFC-BB26-80C7390E1C4AQ37053139-372FEB25-5C82-4F4E-A36E-C70093D117D6Q37200932-0CAD59EB-E117-403E-B697-F740585269A4Q37294968-704A4A2C-D0EB-4D84-BFC1-8AB75C5D6CBFQ39660258-96F06E51-3455-4D17-A69D-B4EF1B13DA3BQ40056277-2A122619-0EF9-4E89-AAEB-7D847D979056Q40184193-879484FA-F4FB-4D39-B591-266830A9C98FQ40613351-E58C35D1-14FE-455C-B0E7-40780A8DA563Q40877772-C4A451F1-1BAE-431F-831F-22DD6ECDEC28Q40878195-908A8E9E-3EE1-4313-BE18-5C1D43B1EDF9Q41181830-41995BFD-77C6-4BFD-9F29-A01912596188Q42840587-B2CA8AC3-1A09-491A-BDB4-E6BD3E1DB37E
P2860
Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV
description
1977 nî lūn-bûn
@nan
1977 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@ast
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@en
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@nl
type
label
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@ast
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@en
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@nl
prefLabel
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@ast
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@en
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@nl
P2093
P2860
P1476
Opsonic requirements for phago ...... ypes VI, XVIII, XXIII, and XXV
@en
P2093
P2860
P304
P407
P577
1977-11-01T00:00:00Z